PLASMODIUM VIVAX MALARIA

Clinical trials for PLASMODIUM VIVAX MALARIA explained in plain language.

Never miss a new study

Get alerted when new PLASMODIUM VIVAX MALARIA trials appear

Sign up with your email to follow new studies for PLASMODIUM VIVAX MALARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New malaria vaccine trial could stop recurring fever in its tracks

⭐️ VACCINE ⭐️ Not yet recruiting

This study tests an experimental malaria vaccine called PvCS/Montanide ISA-51 in 72 healthy adults aged 18-50 in Colombia. The vaccine aims to protect against Plasmodium vivax, a parasite that causes repeated bouts of fever and illness. Participants receive three shots over four …

Matched conditions: PLASMODIUM VIVAX MALARIA

Phase: PHASE2 • Sponsor: Malaria Vaccine and Drug Development Center • Aim: ⭐️ VACCINE ⭐️

Last updated May 17, 2026 11:35 UTC

PLASMODIUM VIVAX MALARIA

Get alerted when new PLASMODIUM VIVAX MALARIA trials appear

New malaria vaccine trial could stop recurring fever in its tracks